Clinical Trials Sponsored by Instituto Jalisciense de Cancerologia

Total 328 results

Instituto Jalisciense de Cancerologia
University of Guadalajara

Unknown

Relationship Between Body Composition, Food Consumption, and Micro and Macronutrients With Gene Expression in Breast Cancer (NUTRIBREAST)

Obesity | Breast Cancer | Nutrition Disorders | Vitamin D Deficiency | Endocrine Therapy | Endocrine Therapy Adverse Reaction

Mexico
Hospital Civil de Guadalajara
Instituto Jalisciense de Cancerologia

Recruiting

The INVADE Study: INnominate Vein Approach for Central Catheterization in Difficult to cannulatE Patients (INVADE)

Critical Illness

Mexico
Instituto Jalisciense de Cancerologia
University of Guadalajara; Instituto Mexicano del Seguro Social

Unknown

Polymorphisms of Interleukins, Glypican, and Human Leukocyte Antigen Genes and Treatment Response in Multiple Sclerosis. (WESTEMDRB1)

Multiple Sclerosis, Relapsing-Remitting

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Treatment With BIBW 2992, Irreversible Inhibitor of EGFR and HER-2 in Non-small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer | EGFR | HER-2

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Radical Treatment of Synchronous Oligometastatic Non-Small Cell Lung Carcinoma

Carcinoma, Non-Small-Cell Lung | Synchronous Neoplasms

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Results From a Mexican Acute Promyelocytic Leukemia. (Mexico APL)

Promyelocytic Leukemia, Acute

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Nitroglycerin Plus Intracranial Radiotherapy for Brain Metastases in NSCLC Patients

Phase II Clinical Trial | Ninety-six Histologically Confirmed NSCLC Patients With BM | Randomized 1:1 to Received TN Plus WBR or Only WBR | ICPFS Evaluated by Two Blinded and Independent Radio-oncologist With MRI

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Clinicopathological Features of NSCLC Patients Associated With the Chromosome 2p (EML4-ALK) (ALK)

Non Small-cell Lung Cancer

Mexico
Instituto Nacional de Cancerologia de Mexico

Unknown

Metformin Plus TKI Use in Patients With Non-Small Cell Lung Carcinoma

EGFR Gene Mutation | Tyrosine Kinase Mutation | Non-Small Cell Adenocarcinoma

Mexico
Instituto Nacional de Cancerologia de Mexico

Unknown

Evaluation of PD1 / PDL1 Expression on Blood Cells & Tumor Tissue, Their Role as a Prognostic Target in NSCLC Patients

Non-Small Cell Lung Cancer

Mexico
Instituto Nacional de Cancerologia, Columbia

Completed

Chemotherapy / Radiotherapy in Uterine Cervical Neoplasms

Uterine Cervical Neoplasms
Instituto Nacional de Cancerologia de Mexico

Recruiting

Glutamine Plus L. Reuteri Prevents TKI Therapy-diarrhea in Patients With NSCLC

Non-Small Cell Lung Cancer With EGFR Mutation

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Ketamine or Placebo in Patients With Major Depression and Advanced Cancer (KODIAC)

Major Depressive Disorder | Advanced Cancer

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib)

Lung Cancer | Skin Rash

Mexico
Instituto Nacional de Cancerologia de Mexico

Unknown

Effectiveness and Quality of Life Analysis of Palonosetron Against Ondansetron Combined With Dexamethasone and Fosaprepitant in Prevention of Acute and Delayed Emesis Associated to Chemotherapy Moderate and Highly Emetogenic in Breast Cancer.

Quality of Life | Breast Neoplasm | Antineoplastic Agents | Antiemetics

Mexico
Instituto Nacional de Cancerologia de Mexico

Unknown

ALK Rearrangements in Lung Adenocarcinoma: Epidemiology in Latin America (CLICaP)

Lung Cancer

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Early Incorporation of Patient and Family to Attention and Care Program in Oncology Versus Standard of Care (PACO)

Lung Neoplasms

Mexico
Instituto Nacional de Cancerologia de Mexico

Unknown

Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Lung Cancer Patients

Anorexia | Non-Small Cell Lung Cancer | Cachexia | Weight Lose

Mexico
Institut Cancerologie de l'Ouest

Not yet recruiting

Prediction in Silico of Pathological Response in a Prospective Cohort Study of Early Breast Cancer Patients (NEOEPICURE)

Breast Cancer

France
Institut Cancerologie de l'Ouest

Not yet recruiting

Music Therapy as a Tool for Anxiety Reduction in Localized Breast Cancer (CENSORIAL)

Breast Cancer | Anxiety | Chemotherapy

France
Institut Cancerologie de l'Ouest

Recruiting

Retrospective and Prospective Evaluation of Scapulohumeral Comfort, Aesthetic Result and Quality of Life (QUARLAMI)

Breast Cancer

France
Institut Cancerologie de l'Ouest

Recruiting

Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in Situ (HORNEO01)

Mastectomy | Ductal Carcinoma in Situ | Extensive Disease

France
Institut Cancerologie de l'Ouest

Recruiting

Impact of Bladder Depletion on Mesorectal Movements During Radiotherapy in Rectal Cancer (MESORECT-VV)

Rectal Cancer

France
Institut Cancerologie de l'Ouest

Recruiting

Study of the Response to Irradiation on Prostatic Explants ex Vivo, as a Predictive Factor of the Clinical Response to Irradiation of Prostate Cancers (EXPLANT)

Prostate Cancer

France
Institut Cancerologie de l'Ouest

Completed

Pain and Functional Recovery After Mastectomy and IBR by Implant: Prepectoral Versus Subpectoral Technique (DREAM-RMI)

Breast Cancer Female

France
Institut Cancerologie de l'Ouest

Completed

Evaluating the Value of Audio-guided Meditation During Breast Biopsy Procedures (MAG-BM)

Breast Disease

France
Institut Cancerologie de l'Ouest

Completed

Breast Reconstruction by Exclusive Lipomodulin : Feasibility, Evaluation of the Aesthetic Result and Quality of Life (EXCLUFAT)

Breast Cancer | Mastectomy; Lymphedema

France
Institut Cancerologie de l'Ouest

Active, not recruiting

Clinico-biological Data Collection Study of Metastatic Lung Cancer (EPICURE_LUNG)

Lung Cancer

France
Institut Cancerologie de l'Ouest

Active, not recruiting

Bringing of PET-TDM FDG in the Determination of the Characteristics of Primary Mammary Tumors TrIple Negatives (FICTION)

Breast Cancer

France
Institut Cancerologie de l'Ouest

Completed

Place of Intrathecal Analgesia to Improve the Quality of Life of Painful Cancer Patients (QUALITHEC01)

Cancer | Injections, Spinal

France
Institut Cancerologie de l'Ouest

Terminated

Evaluation of Impact of Sandostatin® Injection Before Axillary Clearance on Lymphocele Formation (SANDOSTATINE)

Breast Cancer | Lymphocele
Institut Cancerologie de l'Ouest

Completed

Medico-economic Study of Three Strategies of Sentinel Lymph Node Analysis in Operable Breast Cancer (SAGE)

Breast Cancer | Surgery

France
Institut Cancerologie de l'Ouest

Completed

Interest of Touch-massage in Hospital Day Care (TOMAS)

Breast Neoplasm Malignant Female

France
Institut Cancerologie de l'Ouest

Completed

Feasibility of MRI Workflow Alone in External Radiotherapy for the Treatment of Brain and Prostate Tumors (PRIS)

Prostate Cancer | Brain Cancer

France
Institut Cancerologie de l'Ouest

Completed

Medico-economic Evaluation Comparing Intensity-Modulated Radiation Therapy (IMRT) Performed by Helical Tomotherapy and Dynamic Arc Therapy in Prostate, Cervical and Anal Canal Cancers (RCMI PELVIS)

Cervical Cancer | Prostate Cancer | Anal Canal Cancers

France
Institut Cancerologie de l'Ouest

Completed

Study of 68Ga-HBED-PSMA PET/CT and Conventional Imaging in Occult Biological Relapse Prostate Cancer (PSMA REBIOLOC)

Prostate Cancer Recurrent

France
Institut Cancerologie de l'Ouest

Completed

Interest of Reticulocyte Haemoglobin Content (RET-he) in Management of Functional Anemia for Patient With Solid Tumor (RET-HE)

Solid Tumor, Adult | Anemia Deficiency

France
Institut Cancerologie de l'Ouest

Terminated

Phase 1-2 Study of Total Bone Marrow Irradiation With Helicoidal Tomotherapy in 1st Myeloma Relapse (TOMMY)

Multiple Myeloma in Relapse

France
Institut Cancerologie de l'Ouest

Terminated

Pre-emptive Cycline Treatment on Cetuximab Induced Skin Toxicity in Colorectal Cancer (SKINUX)

Colorectal Cancer Metastatic | Skin Toxicity

France
Institut Cancerologie de l'Ouest

Completed

Molecular Biology Analysis for Para-aortic Nodes in the Ultra-staging of Advanced Cervical Cancers (GYNOSNA)

Advanced Cervical Cancer

France
Institut Cancerologie de l'Ouest

Completed

RSHF in Colorectal Cancer (RS CAMPTO)

Metastatic Colorectal Cancer

France
Institut Cancerologie de l'Ouest

Active, not recruiting

Medico Economic Study, Comparing Intrabeam® on Surgical Resection Bed to Conventional Surgery + EBRT, in Breast Cancer (RIOP-SEIN)

Menopausal Patients | Low-risk Breast Cancer

France
Instituto de Cancerología S.A.

Completed

Efficacy of Thoracic Paravertebral Block in the Reduction of Acute Post-surgical Pain in Patients With Breast Cancer

Breast Cancer

Colombia
Instituto Nacional de Cancerologia de Mexico

Recruiting

Nitroglycerin Plus Radiotherapy Versus Conventional Radiotherapy in Patients With Lung Cancer.

Non-small Cell Lung Cancer | Brain Metastases | EGFR Gene Mutation

Mexico
Instituto Nacional de Cancerologia de Mexico

Recruiting

Alectinib Pharmacokinetic in Patients With NSCLC

ALK Gene Mutation | Non-small Cell Lung Cancer Stage IIIB

Mexico
Instituto Nacional de Cancerologia de Mexico

Recruiting

Metformin Plus Tyrosine Kinase Inhibitors for Treatment of Patients With Non-small Cell Lung Cancer With EGFR Mutations (METLUNG)

Non Small Cell Lung Cancer

Mexico
Instituto Nacional de Cancerologia de Mexico

Recruiting

HIPEC in Ovarian Carcinoma Clinical Stage IIIC and IV During Interval Laparotomy

Ovarian Cancer | Chemotherapy Effect | HPEC | Women's Health: Neoplasm of Ovary

Mexico
Instituto Nacional de Cancerologia de Mexico

Recruiting

Pulmonary Rehabilitation in Advanced Non-small Cell Lung Cancer Patients

Quality of Life | Sarcopenia | Pulmonary Rehabilitation

Mexico
Instituto Nacional de Cancerologia de Mexico

Recruiting

Impact of Fat-free Mass in the Carboplatin Calculated Dose and Chemotherapeutic Toxicity in Patients With Advanced NSCLC

Lung Cancer | Sarcopenia | Toxicity

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer

Lung Neoplasms | Small Cell Lung Carcinoma | Non-Small Cell Lung Cancer | Taste Disorders | Dysgeusia

Mexico

Clinical Trials Sponsored by Instituto Jalisciense de Cancerologia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Equatorial Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations